Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 6/20 | 0.35 |
| ▸ | CA2 | P00918 | 6/20 | 0.35 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | CA1 | P00915 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.32 |
| ▸ | RAD52 | P43351 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4874756 | 0.90 | TSHR (0.36) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| Bromide SCHEMBL4872436 | 0.90 | TSHR (0.36) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| Hydrochloric Acid SCHEMBL4874747 | 0.90 | TSHR (0.36) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| SCHEMBL3898673 | 0.88 | LMNA (0.35) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| SCHEMBL4875526 | 0.85 | CA12 (0.39) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| SCHEMBL4863759 | 0.84 | CA12 (0.38) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| SCHEMBL3922900 | 0.84 | IL1R1 (0.35) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| SCHEMBL4872461 | 0.84 | CA12 (0.38) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| SCHEMBL3912416 | 0.82 | CA12 (0.37) | ALDH1A1SMN1; SMN2CA12CA2CA9 | |
| SCHEMBL4869188 | 0.81 | RAB9A (0.42) | ALDH1A1SMN1; SMN2CA12CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7431741-B2 | Brightening colorant with indolythiazolium dyes | WELLA AG (DE) | 2008-10-07 | — | — | US | disclosed |
| US-20070180631-A1 | Brightening colorant with indolythiazolium dyes | Wella GmbH (DE) | 2007-08-09 | — | — | US | disclosed |
| EP-1730239-B1 | LIGHTENING COLORANT CONTAINING INDOLYL THIAZOLIUM AZO DYES | WELLA AG (DE) | 2007-05-02 | — | — | EP | disclosed |
| EP-1730239-A1 | LIGHTENING COLORANT CONTAINING INDOLYL THIAZOLIUM AZO DYES | Wella Aktiengesellschaft (DE) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005080507-A1 | LIGHTENING COLORANT CONTAINING INDOLYL THIAZOLIUM AZO DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070180631-A1 | Brightening colorant with indolythiazolium dyes | KRT18, TUBB1, IK | ALDH1A1 89/4885SMN1; SMN2 4782/4885CA12 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.